Collaboration in Biopharma
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
Top Ten most popular articles on Pharmafile.com this week
October 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …
NHS was crippled by “unsophisticated” cyber attack
October 27, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
Back in May of this year, the NHS was hit by a cyber attack that severely impacted at least 34% …
Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl
October 27, 2017Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids
John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …
Celgene hikes price of Revlimid to mask poor Q3 results
October 27, 2017Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical
Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …
AbbVie’s psoriasis drug smashes all endpoints
October 26, 2017Medical Communications, Research and Development AbbVie, IL-23, biotech, drugs, pharma, pharmaceutical, risankizumab
AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …
Is the NHS prepared for the upcoming winter season?
October 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma
After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …
GSK eyes healthcare expansion, hits targets due to new drugs
October 26, 2017Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical
During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …
Pfizer to begin auction of consumer health division next month
October 26, 2017Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle
Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …
NHS patients could be offered Airbnb-like accommodation
October 26, 2017Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …
Regeneron injects $100 million and 300 new roles into Irish production facility
October 26, 2017Manufacturing and Production Regeneron, Sanofi, manufacturing, pharma
Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …
Mental health problems cause 300,000 to leave work each year
October 26, 2017Research and Development biotech, drugs, mental health, pharma, pharmaceutical
A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …
Sanofi launches patent infringement lawsuit against Mylan over diabetes pen
October 25, 2017Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma
Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …
Lilly looks to leave behind animal health business
October 25, 2017Research and Development, Sales and Marketing Elanco, Eli Lilly, biotech, drugs, pharma, pharmaceutical
Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …
GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost
October 25, 2017Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma
GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
Research finds blood-thinners protect against dementia
October 25, 2017Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical
Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …
Type 3 diabetes more common than Type 1 and often misdiagnosed
October 25, 2017Research and Development biotech, diabetes, drugs, pharma, pharmaceutical
In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …
Novartis Q3: Jimenez talks up Alcon, Gleevec takes generic hammering
October 24, 2017Manufacturing and Production, Sales and Marketing Novartis, biotech, drugs, pharma, pharmaceutical
Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of …
Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head
October 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment
Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
